
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
The Director, Patient Marketing will be a critical member of the Marketing team and will be responsible for the development and execution of patient-focused campaigns for Beam’s asset in Sickle Cell Disease. This leader will shape our digital and patient engagement strategy, driving innovative, compliant, and impactful programs that empower patients and caregivers throughout their journey.
This is a unique opportunity for a strategic, collaborative, and results-oriented Patient marketer to build a high-impact engagement platform in a complex and underserved therapeutic area.
The Director, Patient Marketing will collaborate closely with cross functional partners—including HCP Marketing, Patient Advocacy, Patient Services, Medical Affairs, Regulatory, Legal, Field Teams, and external partners—and will play a critical role in the execution of the brand strategy at launch and beyond.
Responsibilities:
Qualifications:
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.
Beam Pay Range $210,000—$260,000 USD

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.
Our dream is to provide life-long cures for patients suffering from serious diseases.
The Beam Team Is:
• A community of fearless innovators
• Rigorous and honest in our research
• Listening with open minds
• Committed to each other